BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) announced its earnings results on Friday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.
BioNxt Solutions Price Performance
Shares of BNXTF stock opened at $0.28 on Friday. The firm has a 50 day moving average of $0.23 and a two-hundred day moving average of $0.32. The stock has a market capitalization of $37.61 million, a PE ratio of -5.53 and a beta of 0.70. BioNxt Solutions has a 52 week low of $0.14 and a 52 week high of $0.79.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Featured Stories
- Five stocks we like better than BioNxt Solutions
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
